ReleaseWire Connect

Fortune Business Insights foresees the pharmaceutical segment to dominate the global epigenomics market on account of the increasing prevalence of chronic diseases such as cancer. According to the World Health Organization (WHO), by the end of 2025, the number of cancer patients will reach 21,471,996.

Fortune Business Insights provides a detailed evaluation of the Solar Photovoltaic (PV) Market by analyzing the factors driving the market. Besides this, it also discusses some of the economic trends prevailing in the energy and power industry. These trends are analyzed in the report to see an overall impact on the global market.

The Global Alpha-1 Antitrypsin Deficiency (Aatd) Augmentation Therapy Market has been supported by late FDA endorsement for Prolastin-C. According to a report published by Fortune Business Insights, titled "AATD Augmentation Therapy: Global Analysis, Insights and Forecast, 2019-2026", the market will be valued at US$ 1959.8 Mn by the end of 2025.

The increasing incidence of chronic diseases is expected to propel growth in the global biochips based in-vitro diagnostics market. Fortune Business Insights has found this in a report, titled "Biochips Based In-vitro Diagnostics Market Size, Share and Global Trend by Application (DNA applications, Lab-on-chip applications, Protein microarray applications, Other array applications), By End-users (Hospitals & Clinics, Research Institutions, Diagnostic Centers), and Geography Forecast till 2026." As per the report in 2017, North America held the highest share in the global market. The trend witnessed is unlikely to change over the forecast period 2018-2025, and North America is expected to hold its position.

The Global Medical Imaging Equipment Market is likely to grow in the coming years due to the increasing incidence of chronic diseases such as liver, cancer, and cardiovascular diseases. According to a report published by Fortune Business Insights, titled "Medical Imaging Equipment: Global Market Analysis, Insights and Forecasts, 2018-2025," the market is likely to reach US$ 44,077.7 Mn by 2025. The market was valued at US$ 30,814.2 Mn in 2017, and the value will increment at a CAGR of 4.6% during the forecast period.

With recent improvements in mapping technology, the Global Aerial Imaging Market is anticipated to witness robust growth. In a report, titled "Aerial Imaging Market Size, Share and Global Trend By Camera Orientation (Oblique, Vertical), Platform (Fixed-Wing Aircraft, Helicopter, UAV/Drones), End-Use Industry (Government, Energy Sector, Defense, Forestry and Agriculture, Real Estate, Civil Engineering, Insurance) And Geography Forecast till 2025".

The global retinal disease therapeutics market is likely to expand at an impressive rate driven by recent government participation towards prevention and control of retinal diseases. According to a report published by Fortune Business Insights, titled "Retinal Disease Therapeutics: Global Market Analysis, Insights, and Forecast, 2019-2026," the market is likely to reach US$ 21,318.0 Mn by the end of 2026. The market was valued at US$ 11,044.2 Mn in 2018 and is likely to witness a CAGR of 8.6% in the forecast period.

The global orthopedic joint replacement market is anticipated to grow on account of rising geriatric population and su8bsequently rising demand in developed and developing nations. Fortune Business Insights in its new report, titled "Orthopedic Joint Replacement Market: Global Market Analysis, Insights and Forecast, 2018-2026" offers in-depth insights into the market. As per the report, the global orthopedic joint replacement was worth US$ 19051.2 Mn in the year 2018 and is estimated to reach US$ 26967.9 Mn by the end of 2026. Furthermore, it is projected that the global market for orthopedic joint replacement market will exhibit a CAGR of 5.1% from 2019 to 2026.

Rising demand for novel therapeutics among aging population will enable growth in the global glaucoma therapeutics market. Recently Fortune Business Insights has published a report, titled "Glaucoma THERAPEUTICS: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2019-2026." According to the report, in 2018 the global glaucoma therapeutics market was worth US$ 6273.5 Mn. However, the global market is anticipated to expand at a CAGR of 6.1% and reach US$ 10,091 Mn by the end of 2026. The report also classifies the global glaucoma therapeutics market on the basis of various segments.

The rising demand for advanced drugs is likely to create lucrative growth opportunities for the global veterinary drugs market, finds Fortune Business Insights in their new study. The study is titled "Veterinary Drugs Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2025." According to the study, the global veterinary drugs market will reach a valuation of US$ 27,570 Mn by 2025 from US$ 17,870.6 Mn in 2017, and exhibit a promising CAGR of 5.6% over the aforementioned forecast period.